back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-07-03 19:29 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Lamb, Damian Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2016-11-19 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventrues III LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-19 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventrues III LP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,999,999
+2,727,272 vol $1.10 each |
2,727,272 | |
| Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventures II L.P, (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,100,872 |